Form D · Pharmaceuticals
Actimis Pharmaceuticals Inc
San Mateo, CA · CIK 0001313836
Offering snapshot reported Jun 19, 2017 · SEC filing
- Reported sold
- $452K Offering amount: $1M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 13, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 19, 2017 | Initial | $452,001 | No comparison | 5 | SEC filing |
| Sep 21, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 3, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 19, 2006 | Paper | Not reported | No comparison | Not reported | |
| Jul 5, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 5, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-288964
Source: Form D, filed Jun 19, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kevin Bacon | Director, Executive |
| Masaji Matsuoka | Director |
| Peter Mc Williams | Director, Executive |
| Fred Middleton | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
400 S. El Camino Real, Suite 1200
San Mateo, CA, 94402
San Mateo, CA, 94402